Welcome to the tag category page for Drug development!
Farxiga is a prescription medicine used to improve blood sugar control in adults with type 2 diabetes, reduce the risk of hospitalization for heart failure in adults with type 2 diabetes and known cardiovascular disease or multiple cardiovascular risk factors, and treat chronic kidney disease and heart failure. Farxiga is an oral diabetes medicine that helps control blood sugar levels by helping the kidneys get rid of glucose. It belongs to a class of medications called sodium-glucose cotransporter 2 (SGLT2) inhibitors. Common side effects include hypoglycaemia, urinary tract infections, genital infections, and volume depletion. In clinical studies, people taking Farxiga lost up to about 7 pounds (3 kilograms) over 24 weeks of treatment. Farxiga is also known as dapagliflozin and Forxiga.
